Trimipramine and other antipsychotics inhibit Campylobacter pylori in vitro. 1989

J E Kristiansen, and T Justesen, and E F Hvidberg, and L P Andersen
Department of Clinical Microbiology, Central Hospital, Hillerød, Denmark.

A series of conventional anti-ulcer drugs, tricyclic antidepressants and neuroleptics (and some CNS non-active isomers) were tested in vitro for possible inhibition of Campylobacter pylori. These bacteria are claimed to play an etiological role in peptic ulcer disease, at least in gastritis B. While cimetidine, famotidine, ranitidine and pirenzepine were inactive, all the antipsychotic agents and their isomeric derivatives were active to various degrees with IC50 of 26-59 microM. Of special interest is trimipramine (Surmontil) that has been demonstrated to be effective against duodenal ulcers in some trials. The activity of the non-neuroleptic stereo-isomers of clopenthixol and chlorprothixene may lead to investigation in patients with peptic ulcer disease of this kind of agents. However, a firm connection between the antimicrobial activity of these compounds, their possible anti-ulcer effect and the etiological role of Campylobacter pylori in peptic ulcer disease must first be established.

UI MeSH Term Description Entries
D002167 Campylobacter A genus of bacteria found in the reproductive organs, intestinal tract, and oral cavity of animals and man. Some species are pathogenic.
D003984 Dibenzazepines Compounds with two BENZENE rings fused to AZEPINES.
D000897 Anti-Ulcer Agents Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. Anti-Ulcer Drugs,Agents, Anti-Ulcer,Anti Ulcer Agents,Anti Ulcer Drugs,Drugs, Anti-Ulcer
D000928 Antidepressive Agents Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. Antidepressant,Antidepressant Drug,Antidepressant Medication,Antidepressants,Antidepressive Agent,Thymoanaleptic,Thymoanaleptics,Thymoleptic,Thymoleptics,Antidepressant Drugs,Agent, Antidepressive,Drug, Antidepressant,Medication, Antidepressant
D014150 Antipsychotic Agents Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. Antipsychotic,Antipsychotic Agent,Antipsychotic Drug,Antipsychotic Medication,Major Tranquilizer,Neuroleptic,Neuroleptic Agent,Neuroleptic Drug,Neuroleptics,Tranquilizing Agents, Major,Antipsychotic Drugs,Antipsychotic Effect,Antipsychotic Effects,Antipsychotics,Major Tranquilizers,Neuroleptic Agents,Neuroleptic Drugs,Tranquillizing Agents, Major,Agent, Antipsychotic,Agent, Neuroleptic,Drug, Antipsychotic,Drug, Neuroleptic,Effect, Antipsychotic,Major Tranquilizing Agents,Major Tranquillizing Agents,Medication, Antipsychotic,Tranquilizer, Major
D014299 Trimipramine Tricyclic antidepressant similar to IMIPRAMINE, but with more antihistaminic and sedative properties. Trimeprimine,10,11 Dihydro-N,N,beta-trimethyl-5H-dibenz(b,f)azepine-5-propanamine,Apo-Trimip,Eldoral,Herphonal,Novo-Tripramine,Nu-Trimipramine,Rhotrimine,Stangyl,Surmontil,Surmontil Maleate,Trimidura,Trimineurin,Trimineurin Maleate,Trimipramin AZU,Trimipramin Beta,Trimipramin Stada,Trimipramin-Neurazpharm,Trimipramine Maleate,Trimipramine Maleate (1:1),Trimipramine Maleate (1:1), (+)-Isomer,Trimipramine Maleate (1:1), (+-)-Isomer,Trimipramine Maleate (1:1), (-)-Isomer,Trimipramine Mesylate,Trimipramine Monohydrochloride,Trimipramine, (+-)-Isomer,Trimipramine, (-)-Isomer,Apo Trimip,ApoTrimip,Beta, Trimipramin,Novo Tripramine,NovoTripramine,Nu Trimipramine,NuTrimipramine,Trimipramin Neurazpharm,TrimipraminNeurazpharm

Related Publications

J E Kristiansen, and T Justesen, and E F Hvidberg, and L P Andersen
July 1989, Journal of chemotherapy (Florence, Italy),
J E Kristiansen, and T Justesen, and E F Hvidberg, and L P Andersen
September 1989, American journal of clinical pathology,
J E Kristiansen, and T Justesen, and E F Hvidberg, and L P Andersen
January 1989, Antimicrobial agents and chemotherapy,
J E Kristiansen, and T Justesen, and E F Hvidberg, and L P Andersen
May 1989, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
J E Kristiansen, and T Justesen, and E F Hvidberg, and L P Andersen
December 1989, The Journal of antimicrobial chemotherapy,
J E Kristiansen, and T Justesen, and E F Hvidberg, and L P Andersen
August 1989, The Journal of antimicrobial chemotherapy,
J E Kristiansen, and T Justesen, and E F Hvidberg, and L P Andersen
August 1988, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
J E Kristiansen, and T Justesen, and E F Hvidberg, and L P Andersen
December 1988, Infection and immunity,
J E Kristiansen, and T Justesen, and E F Hvidberg, and L P Andersen
June 1987, Antimicrobial agents and chemotherapy,
J E Kristiansen, and T Justesen, and E F Hvidberg, and L P Andersen
October 1989, Journal of clinical microbiology,
Copied contents to your clipboard!